pharma · Anorectal Disorder · Localized Primary Osteoarthritis of Both Hips (Diagnosis)
Chia Tai Tianqing
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Chia Tai Tianqing is a pharma organization headquartered in CN. Primary therapeutic focus areas include Anorectal Disorder, Localized Primary Osteoarthritis of Both Hips (Diagnosis), Recovery of Bowel Function, Due to Gu
Company details
- Status
- Public
- HQ
- Lianyungang, CN
- Employees
- 366
- Programs
- 11
- Drugs
- 15
- Patents
- 0
Dexamethasone
Approved · small molecule · Localized Primary Osteoarthritis of Both Hips (Diagnosis)
Dexamethasone for Localized Primary Osteoarthritis of Both Hips (Diagnosis) is a Approved program (small_molecule) at Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code ORT-2559-03928
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Localized Primary Osteoarthritis of Both Hips (Diagnosis)
- Status
- active
- Trials
- 1